ODTXOdyssey Therapeutics Inc

$18.43
$0.61
(3.41%)
Today
Closed $18.48
$0.05
(0.27%)
After Hours
Updated: 07:27 PM EDT
Mkt Cap$843M
Vol471,203.00

About

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Odyssey Therapeutics Inc?
What is the 52-week high for Odyssey Therapeutics Inc?
What is the 52-week low for Odyssey Therapeutics Inc?
What is Odyssey Therapeutics Inc stock price today?
What was Odyssey Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Odyssey Therapeutics Inc?

Advertisement|Remove ads.